Conference Commentary: Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Cluster Randomized Trial

Yatin Mehta, MD, comments on the findings of a randomized trial reporting no difference in ICU-acquired bloodstream infections caused by multidrug-resistant gram-negative bacteria (MDRGNB) among ventilated ICU patients given chlorhexidine 2% mouthwash, selective oropharyngeal decontamination (mouthpaste with colistin, tobramycin, and nystatin), or selective digestive tract decontamination (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. Comments were made at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.